🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to assess safety of FIXFc at doses ra...
Status
Completed
Location
RUSH University Medical Center
Start Date
2008-04
Trial ID
NCT00716716
Treatments Being Tested
The primary objective of the study is to evaluate the effectiveness of prop...
Status
Terminated
Location
Research Site
Start Date
2015-07
Trial ID
NCT02392156
Treatments Being Tested
The primary objective of the study was to evaluate the safety of recombinan...
Status
Completed
Location
Research Site
Start Date
2014-11-13
Trial ID
NCT02234310
Treatments Being Tested
Alprolix (rFIXFc) is a recombinant extended half-life coagulation factor pr...
Status
Completed
Location
Swedish Orphan Biovitrum Research Site (CHU de Bordeaux)
Start Date
2018-09-12
Trial ID
NCT03655340
Treatments Being Tested
Alprolix (rFIXFc) is a recombinant extended half-life coagulation factor pr...
Status
Completed
Location
Swedish Orphan Biovitrum Research Site
Start Date
2019-09-12
Trial ID
NCT03901755
Treatments Being Tested
Recombinant factor VIII Fc (rFVIIIFc) and recombinant factor IX Fc (rFIXFc)...
Status
Completed
Location
BC Hemophilia Adult Program
Start Date
2016-04
Trial ID
NCT02796222
Elocta (rFVIIIFc) and Alprolix (rFIXFc) are recombinant extended half-life ...
Status
Completed
Location
Swedish Orphan Biovitrum Reserach site
Start Date
2017-05-09
Trial ID
NCT03055611
The primary objective of the study is to evaluate the safety of Recombinant...
Status
Completed
Location
Research Site
Start Date
2012-06
Trial ID
NCT01440946
The primary objectives of the study were: to evaluate the safety and tolera...
Status
Completed
Location
Research Site
Start Date
2009-12
Trial ID
NCT01027364
Treatments Being Tested
The primary objective of the study is to evaluate the long-term safety of r...
Status
Completed
Location
Research Site
Start Date
2011-12-08
Trial ID
NCT01425723
Treatments Being Tested